Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab with Short-course Radiotherapy and CAPOX in Rectal Cancer
NCT04663763Phase 2Not yet recruiting
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Dec 2020
- Primary completion
- Dec 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in locally advanced rectal cancer (LARC), sponsored by Zhejiang Cancer Hospital. Planned start Dec 2020; status: not yet recruiting.
02
Drugs
sintilimab
03
Conditions
locally advanced rectal cancer (LARC)
Beyond the preview
Go deeper on NCT04663763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04663763.